GAAP net income was $13.1 million, or $0.26 per diluted share; adjusted EBITDA increased 14% to $41.5 million; adjusted net income rose 24% to $23.4 million and adjusted diluted EPS increased 24% to $0.46

Vinyl revenue increases 13% to $383 million; CD revenue rises 25% to $156 million

Physical movie revenue increases 22% as relationships with Paramount and Amazon MGM Studios reinforce Alliance’s position as a scaled physical entertainment distribution partner

Collectibles revenue increases 45% as Alliance expands its portfolio of higher-value, premium and proprietary products

PLANTATION, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, reported its financial and operational results for its fiscal year ended June 30, 2026.

Fiscal 2026 Financial Highlights

  • Net Revenues: Increased 8% to $1.149 billion, compared with $1.063 billion in fiscal 2025.
  • Gross Profit and Margin: Gross profit increased 15% to $152.3 million from $132.9 million, while gross margin expanded 80 basis points to 13.3% from 12.5%.
  • GAAP Results: Operating income was $27.2 million and net income was $13.1 million, compared with $30.1 million and $15.1 million, respectively. Fiscal 2026 included a $7.8 million non-cash write-off of a historical vendor rebate receivable.
  • Adjusted EBITDA: Increased 14% to $41.5 million, compared with $36.5 million in fiscal 2025.
  • Adjusted Net Income and Adjusted Diluted EPS: Adjusted net income increased 24% to $23.4 million, compared with $18.9 million in fiscal 2025, while adjusted diluted earnings per share increased 24% to $0.46 from $0.37.
  • Interest Expense: Decreased 28% to $7.6 million from $10.6 million, reflecting a lower average effective interest rate following the Company’s refinancing.
  • Cash Flow and Liquidity: Net cash used in operating activities was $1.7 million, compared with $26.8 million of net cash provided in fiscal 2025, primarily reflecting increased inventory and receivables to support growth. The Company ended fiscal 2026 with $45.7 million of availability under its $120 million revolving credit facility.

“Fiscal 2026 demonstrated that the strategy we have been executing is strengthening both the quality of our business and our position across the entertainment ecosystem,” said Jeff Walker, Chief Executive Officer of Alliance Entertainment. “The market for physical entertainment continues to evolve toward premium formats, collectible products and more specialized distribution, and those changes are playing directly to the capabilities we have built over more than three decades. Our expanding relationships with major content owners, including Paramount and Amazon MGM Studios, reinforce the value of our scale, infrastructure, and ability to manage increasingly complex physical entertainment programs across wholesale, retail, and e-commerce channels.”

“Our opportunity is increasingly broader than traditional distribution,” Walker continued. “We are using the same infrastructure and relationships that support our core business to expand into higher-value collectibles, proprietary products, fulfillment services and new capabilities such as authentication and digital product identity. Our focus is not simply on putting more volume through the platform, but on improving the value and economics of what moves through it. As the entertainment market becomes more specialized and content owners and retailers look for scaled partners that can manage that complexity, we believe Alliance is increasingly well positioned to capture those opportunities and create durable long-term value.”

“Fiscal 2026 was a year of strong execution for Alliance Entertainment,” said Amanda Gnecco, Chief Financial Officer of Alliance Entertainment. “We expanded gross margins, grew gross profit faster than revenue and delivered growth in adjusted EBITDA, adjusted net income and adjusted diluted earnings per share. These results demonstrate the progress we’ve made in strengthening the earnings profile of the business while continuing to invest in the products, capabilities and partnerships that support our long-term growth strategy.”

“Looking ahead to fiscal 2027, we are excited about the opportunities in front of us,” Gnecco added. “Our focus remains on driving profitable growth, improving cash generation and increasing operating leverage as we continue to scale the business. Combined with lower borrowing costs, solid liquidity and continued investment in automation and technology, we believe we are well positioned to deliver continued value for our customers, partners and shareholders.”

Strategic & Operating Highlights

  • Physical Music Demand Remained Strong Across Formats: Vinyl revenue increased 13% to $383 million, while CD revenue increased 25% to $156 million. Growth across both formats reflects sustained consumer demand for physical ownership, premium editions and collectible-oriented releases, reinforcing the durability of physical music as an important part of Alliance’s portfolio.
  • Home Entertainment Growth Reinforced Alliance’s Strategic Position with Major Studios: Physical movie revenue increased 22% to $339 million, supported by higher unit volumes and the Company’s expanding studio relationships. Alliance’s exclusive physical-media distribution relationship with Paramount and the addition of Amazon MGM Studios during fiscal 2026 further strengthen the Company’s role as a scaled partner for content owners seeking to manage physical entertainment distribution across wholesale, retail and e-commerce channels.
  • Collectibles Continued to Expand as a Higher-Value Growth Category: Collectibles revenue increased 45% to $32 million, supported by higher average selling prices, expanded licensed merchandise offerings and continued development of proprietary products. The Company is leveraging its existing entertainment relationships and distribution infrastructure to broaden its participation in premium fan and collector categories, including through its owned Handmade by Robots™ brand.
  • Fulfillment Growth and Automation Investments Enhanced Platform Scalability: Distribution and fulfillment fee revenue increased 26% to $18.6 million as Alliance continued to expand its role as an omnichannel logistics and fulfillment partner. During fiscal 2026, the Company ordered 5,000 additional totes for its AutoStore system, increasing capacity to 57,000 totes and supporting higher throughput while maintaining fulfillment labor efficiency.
  • Authentication and Digital Identity Expanded Alliance’s Platform Capabilities: Following the acquisition and integration of Endstate, Alliance continued developing NFC-enabled authentication and digital product identity capabilities through Endstate Authentic and Alliance Authentic™. These initiatives are designed to extend the Company’s participation beyond initial product distribution into areas such as authenticated ownership, provenance, brand protection and resale, creating additional long-term opportunities across premium physical products and collectibles.

Fiscal 2026 Financial Review

The improvement in gross margin during fiscal 2026 reflected stronger margins in physical movies and collectibles, increased contribution from premium and exclusive content, favorable product mix and returns activity, and lower wholesale freight costs as a percentage of sales. A portion of the increase in gross profit was offset by higher selling, general and administrative expenses, which increased to $66.0 million from $56.0 million, primarily reflecting higher payroll and employee-related costs to support growth, as well as increased consulting and professional-service costs associated with strategic initiatives and public-company operations. Fiscal 2026 also included a $7.8 million non-cash write-off of a historical vendor rebate receivable associated with Tastemakers following the counterparty’s cessation of operations. The Company does not consider this charge representative of its ongoing operating performance.

Operating cash flow in fiscal 2026 was principally affected by increased working-capital investment to support the Company’s higher revenue base and anticipated customer demand. Working capital increased to $62.4 million at June 30, 2026, from $45.4 million a year earlier. Inventory and trade receivables increased at rates above the Company’s 8% revenue growth during the year, contributing to the year-over-year decline in operating cash flow. In fiscal 2027, management’s objective is to convert a greater share of earnings into operating cash flow by moderating working-capital growth relative to revenue, increasing inventory productivity and strengthening receivable collections.

The Company benefited from lower borrowing costs during fiscal 2026, with its average effective interest rate declining to 6.1% from 9.2% following its refinancing with Bank of America in October 2025. The Company had $74.3 million outstanding under its $120 million revolving credit facility, with $45.7 million of remaining availability, The facility also provides, subject to certain conditions and lender consent, for up to $50 million of additional borrowing capacity, providing further potential financial flexibility as the business grows. The Company was in compliance with applicable covenants at year-end. During fiscal 2026, the Company also repaid $10.0 million of related-party borrowings, further simplifying its financing structure.

Conference Call

Alliance Entertainment Chief Executive Officer Jeff Walker, Chief Financial Officer Amanda Gnecco, and Executive Chairman Bruce Ogilvie will host the conference call, which will be followed by a question-and-answer session. A presentation will accompany the call and can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.

To access the call, please use the following information:

Date: Thursday, September 10, 2026
Time: 4:30 p.m. Eastern Time, 1:30 p.m. Pacific Time
Toll-free dial-in number: 1-877-407-0784
International dial-in number: 1-201-689-8560
Conference ID: 13762431

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact RedChip Companies at 1-407-644-4256.

The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1774079&tp_key=92e32c8d84 and via the investor relations section of the Company’s website here.

A telephone replay of the call will be available approximately three hours after the call concludes and can be accessed through October 10, 2026, using the following information:

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 13762431


About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles. The Company also owns and develops proprietary brands and platforms, including Handmade by Robots™ and Alliance Authentic™, while Endstate Authentic adds NFC-enabled authentication and digital product identity capabilities supporting provenance, brand protection and authenticated resale. Leveraging decades of industry relationships and distribution, fulfillment and inventory-management expertise, Alliance reaches more than 35,000 retail and e-commerce storefronts, connecting entertainment franchises and collectible products with consumers across channels and generations.

For more information, visit www.aent.com.

Forward Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; risks that a breach of the revolving credit facility could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, uncertainty regarding tariffs, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

For investor inquiries, please contact:

Dave Gentry
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
AENT@redchip.com

             
ALLIANCE ENTERTAINMENT HOLDING CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
 
             
    Year Ended     Year Ended  
($ in thousands except share and per share amounts)   June 30, 2026     June 30, 2025  
Net Revenues   $ 1,148,986     $ 1,063,457  
Cost of Revenues (excluding depreciation and amortization)     996,662       930,605  
Operating Expenses                
Distribution and Fulfillment Expense     44,960       40,375  
Selling, General and Administrative Expense     66,169       55,992  
Depreciation and Amortization     5,359       5,334  
Loss on Vendor Receivable     7,823          
Transaction Costs     1,213       957  
Insurance Claim Recovery     (395 )     –  
Restructuring Cost     –       73  
Gain on Disposal of Fixed Assets     (24 )     (15 )
Total Operating Expenses     125,105       102,716  
Operating Income     27,219       30,136  
Other Expenses                
Interest Expense     7,606       10,575  
State tax Benefit from prior year     (51 )        
Change in Fair Value of Warrants     850       853  
Total Other Expenses     8,405       11,428  
Income Before Income Tax Expense     18,814       18,708  
Income Tax Expense     5,756       3,630  
Net Income     13,058       15,078  
Other Comprehensive Income (Loss)                
Foreign Currency Translation     (1 )     3  
Total Comprehensive Income     13,057       15,081  
Net Income per Share – Basic   $ 0.26     $ 0.30  
Weighted Average Common Shares Outstanding – Basic     50,963,975       50,957,370  
Net Income per Share – Diluted     0.26       0.30  
Weighted Average Common Shares Outstanding – Diluted     51,051,740       51,016,546  

             
ALLIANCE ENTERTAINMENT HOLDING CORP.
CONSOLIDATED BALANCE SHEETS
 
             
($ in thousands, except per share amounts)   June 30, 2026     June 30, 2025  
Assets                
Current Assets                
Cash   $ 814     $ 1,236  
Trade Receivables, Net of Allowance for Credit Losses of $811 and $867, respectively     111,038       95,027  
Inventory, Net     126,599       102,848  
Other Current Assets     9,843       19,021  
Total Current Assets     248,294       218,132  
Property and Equipment, Net     10,564       11,291  
Operating Lease Right-Of-Use Assets, Net     16,062       19,214  
Goodwill     94,081       89,116  
Intangibles, Net     18,457       18,475  
Other Long-Term Assets     9,932       789  
Deferred Tax Asset, Net     210       4,211  
Total Assets   $ 397,600     $ 361,228  
Liabilities and Stockholders’ Equity                
Current Liabilities                
Accounts Payable   $ 170,958     $ 155,300  
Accrued Expenses     8,361       9,548  
Current Portion of Operating Lease Obligations     3,329       3,229  
Current Portion of Finance Lease Obligations     1,937       3,075  
Deferred Consideration     1,300       –  
Contingent Liability     –       1,577  
Total Current Liabilities     185,885       172,729  
Revolving Credit Facility, Net     73,721       55,268  
Finance Lease Obligation, Non- Current     –       1,931  
Operating Lease Obligations, Non-Current     14,217       17,432  
Shareholder Loan (subordinated), Non-Current     –       10,000  
Contingent Liability, Non-Current     5,500       –  
Acquired Royalty Obligation (Endstate), Non-Current     165       –  
Warrant Liability     1,496       646  
Total Liabilities     280,984       258,006  
Commitments and Contingencies (Note 12)                
Stockholders’ Equity                
Preferred Stock: Par Value $0.0001 per share, Authorized 1,000,000 shares, Issued and Outstanding 0 shares as of June 30, 2026 and June 30, 2025     –       –  
Common Stock: Par Value $0.0001 per share, Authorized 550,000,000 shares at June 30, 2026, and at June 30, 2025; Issued and Outstanding 50,979,630 shares at June 30, 2026, and 50,957,370 at June 30, 2025, respectively     5       5  
Paid In Capital     48,907       48,570  
Accumulated Other Comprehensive Loss     (77 )     (76 )
Retained Earnings     67,781       54,723  
Total Stockholders’ Equity     116,616       103,222  
Total Liabilities and Stockholders’ Equity   $ 397,600     $ 361,228  

             
ALLIANCE ENTERTAINMENT HOLDING CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
             
    Year Ended     Year Ended  
($ in thousands)   June 30, 2026     June 30, 2025  
Cash Flows from Operating Activities:                
Net Income   $ 13,058     $ 15,078  
Adjustments to Reconcile Net Income to                
Net Cash Provided by Operating Activities:                
Depreciation of Property and Equipment     1,793       1,828  
Amortization of Intangible Assets     3,567       3,506  
Amortization of Deferred Financing Costs (Included in Interest Expense)     2,086       1,404  
Allowance for Credit Losses     1,445       1,068  
Change in Fair Value of Warrants     850       853  
Deferred Income Taxes     4,001       2,322  
Non-cash lease expense     3,152       2,910  
Stock-based Compensation Expense     337       58  
Gain on Disposal of Fixed Assets     (24 )     (15 )
Changes in Assets and Liabilities                
Trade Receivables     (17,455 )     (6,080 )
Inventory     (23,751 )     (4,665 )
Income Taxes Receivable     (600 )     (384 )
Operating Lease Obligations     (3,115 )     (1,731 )
Other Assets     462       (11,340 )
Accounts Payable     15,658       22,079  
Accrued Expenses and Contingent Liability     (3,164 )     (82 )
Net Cash (Used In) Provided By Operating Activities     (1,700 )   $ 26,809  
Cash Flows from Investing Activities:                
Capital Expenditures     (1,074 )     (54 )
Cash Inflow from Asset Disposal     30       15  
Investment in Captive Stock (Equity Component)     173       –  
Cash Paid for Business Acquisition/Asset Purchase     (1,150 )     (7,595 )
Cash Paid for Contract     –       (500 )
Net Cash Used in Investing Activities     (2,021 )     (8,134 )
Cash Flows from Financing Activities:                
Payments on Financing Leases     (3,069 )     (2,848 )
Payments on Revolving Credit Facility     (1,142,898 )     (986,132 )
Borrowings on Revolving Credit Facility     1,159,913       970,409  
Payments on Shareholder Note (Subordinated), Current     (10,000 )     –  
Deferred Financing Costs     (646 )     –  
Net Cash Provided By (Used In) Financing Activities     3,300       (18,571 )
Net (Decrease)/Increase in Cash     (421 )     104  
Net Effect of Currency Translation on Cash     (1 )     3  
Cash, Beginning of the Year     1,236       1,129  
Cash, End of the Year   $ 814     $ 1,236  
Supplemental disclosure for Cash Flow Information                
Cash Paid for Interest   $ 7,530     $ 9,171  
Cash Paid for Income Taxes   $ 2,452     $ 1,727  
Supplemental Disclosure for Non-Cash Investing and Financing Activities                
Conversion of Warrants from liability to Equity   $ –       454  
Contract Acquisition   $ –       1,800  
                 

Non-GAAP Financial Measures: EBITDA, Adjusted EBITDA, Adjusted Net Income, and Adjusted Earnings per Diluted Share (collectively, the “Non-GAAP Financial Measures”) are supplemental measures of our performance that are not required by, or presented in accordance with, U.S. GAAP. The Non-GAAP Financial Measures are not measurements of our financial performance under U.S. GAAP and should not be considered as alternatives to net income, earnings per share or any other performance measure derived in accordance with U.S. GAAP. We define EBITDA as net income before interest expense, net, income tax expense, depreciation and amortization. We define Adjusted EBITDA as EBITDA further adjusted for non-cash charges related to equity-based compensation programs, acquisition and deal-related costs, changes in the fair value of warrants and vendor transaction loss, insurance claim recoveries, and restructuring costs and net gains and losses on the disposal of assets. We define Adjusted Net Income as net income adjusted for the impact of certain non-cash charges and other items that we do not consider in our evaluation of ongoing operating performance. These items include, among other things, non-cash charges related to equity-based compensation programs, acquisition and deal-related costs, amortization of acquisition-related intangible assets, amortization of deferred financing costs, changes in the fair value of warrants and litigation costs and settlements, regulatory assessments and insurance settlements, and the income tax expense effect of these adjustments. We define Adjusted Earnings per Diluted Share as Adjusted Net Income divided by the weighted-average shares outstanding used in the calculation of diluted earnings per share in accordance with U.S. GAAP.

We caution investors that amounts presented in accordance with our definitions of the Non-GAAP Financial Measures may not be comparable to similar measures disclosed by our competitors, because not all companies and analysts calculate the Non-GAAP Financial Measures in the same manner. We present the Non-GAAP Financial Measures because we consider them to be important supplemental measures of our performance and believe they are frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including these Non-GAAP Financial Measures as a reasonable basis for comparing our ongoing results of operations.

The following tables reconcile the Non-GAAP Financial Measures to the most directly comparable U.S. GAAP financial performance measure, which is net income, for the years presented:

    Year Ended     Year Ended  
(in thousands, except share and per share data)   June 30, 2026     June 30, 2025  
Net income   $ 13,058     $ 15,078  
Equity-based compensation (1)     337       58  
Acquisition and deal-related costs (2)     1,213       957  
Amortization of acquisition-related intangible assets (3)     390       180  
Amortization of deferred financing costs (4)     2,086       1,404  
Change in fair value of warrants and contingent consideration (5)     850       853  
Loss on Vendor Receivable (6)     7,823       –  
Litigation costs and settlements (7)     1,267       1,424  
Insurance Claim Recovery (8)     (395 )     —  
Income tax effect of adjustments (9)     (3,180 )     (1,006 )
Adjusted net income   $ 23,449     $ 18,948  
Weighted-average shares outstanding—basic     50,963,975       50,957,370  
Effect of dilutive securities     87,765       8,600  
Weighted-average shares outstanding—diluted     51,051,740       50,965,970  
Earnings per diluted share   $ 0.26     $ 0.30  
Adjusted earnings per diluted share   $ 0.46     $ 0.37  

($ in thousands)   Year Ended June 30, 2026     Year Ended June 30, 2025  
Net income   $ 13,058     $ 15,078  
Add back:                
Interest expense, net     7,606       10,575  
Income tax expense     5,756       3,630  
Depreciation and amortization (10)     5,359       5,334  
EBITDA     31,779       34,617  
Adjustments:                
Acquisition and deal-related costs (2)     1,213       957  
Restructuring costs (11)     —       73  
Loss on vendor receivable (6)     7,823       —  
Equity-based compensation (1)     337       58  
Change in fair value of warrants and contingent consideration (5)     850       853  
Insurance claim recovery (8)     (395 )     —  
State tax benefit from Prior Year (13)     (51 )     –  
Gain on disposal of property and equipment (12)     (24 )     (15 )
Adjusted EBITDA   $ 41,532     $ 36,543  

(1) Represents non-cash charges related to equity-based compensation programs, which vary from period to period depending on the timing of awards.
(2) Represents costs incurred in connection with completed and contemplated business combinations, including advisory, legal, accounting and other professional fees.
(3) Represents amortization of intangible assets acquired in business combinations. The revenue generated by those intangible assets is not excluded from the Non-GAAP Financial Measures.
(4) Represents amortization of debt issuance costs incurred in connection with our credit facility with Bank of America and the terminated White Oak Credit Facility.
(5) Represents non-cash gains and losses resulting from the remeasurement of warrant liabilities and contingent consideration to fair value at each reporting date.
(6) Represents a loss recognized on a receivable due from a vendor for rebates owed before the company went out of business.
(7) Represents legal fees, settlement amounts and other costs associated with litigation matters that we do not consider indicative of our ongoing operating performance.
(8) Represents recoveries received under insurance claims
(9) Represents the income tax effect of the above adjustments. This adjustment uses a blended federal and state statutory income tax rate of 25% for all periods presented and is applied only to those adjustments that carry an income tax consequence. Changes in the fair value of warrants and contingent consideration are not deductible for income tax purposes and accordingly have not been tax effected. 
(10) Represents total depreciation and amortization determined in accordance with U.S. GAAP, which includes amortization of acquisition-related intangible assets. Accordingly, no separate adjustment for that amortization is presented in the reconciliation of EBITDA to Adjusted EBITDA.
(11) Represents restructuring costs.
(12) Represents net gains and losses on the disposal of property and equipment.
(13) State Tax refund for abandoned property

Tenable credits market share leadership to continued platform innovation, including agentic AI advancements and demand for securing AI environments

COLUMBIA, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) — Tenable® Holdings, Inc. (NASDAQ: TENB), the exposure management company, today announced that it has been ranked first in worldwide market share in the IDC Worldwide Device Vulnerability and Exposure Management Market Shares report (doc #US53903826, August 2026).

Exposure management is a fundamental and necessary shift in how businesses perceive and reduce risk in the AI era. Defenders have reached a crossroads: the volume of critical and complex threats has increased exponentially, and they have increasingly less time to assess and respond before AI-enabled attackers strike. The Tenable One Exposure Management Platform was purpose-built to address this challenge, helping customers better understand cyber risk, prioritize action and defend against evolving cyberattacks.

According to the IDC Market Shares report, “Tenable held its ground as the clear market leader, retaining 24.6% share in the worldwide device vulnerability and exposure management market, which is nearly $260 million ahead of its nearest competitor.”

Tenable credits its market share position to its ongoing platform advancements designed to unify visibility, deliver precise contextualized exposure intelligence, and accelerate and automate action across the enterprise. In recent months, Tenable introduced autonomous, always-on capabilities in Tenable Hexa AI, the agentic AI engine of Tenable One, expanded Tenable One AI Exposure capabilities to cover all major AI platforms and developer tools, expanded coverage into application security environments and extended its platform’s continuous security control and validation capabilities.

Tenable is committed to actively shaping the future of AI-driven exposure management through continued platform innovation and strategic work with OpenAI and Anthropic. In addition to participating in both the OpenAI Daybreak Defense Network and Anthropic’s Project Glasswing, Tenable recently announced the availability of Claude Mythos 5 within Tenable One, helping customers better understand cyber risk, prioritize action and defend against evolving cyberattacks.

“We believe our eight consecutive years of market share leadership reflect our commitment to delivering the continuous innovation that sets the standard for exposure management,” said Mark Thurmond, co-chief executive officer, Tenable. “We’re empowering customers to transform their organization’s defense for the AI era by equipping them with the comprehensive visibility, advanced analytics and AI technology required to outpace today’s adversaries.”

“It can’t be overstated: exposure management is foundational and thus necessary to understand, validate and prioritize exposures before they can be exploited by AI-enabled attackers,” said Michelle Abraham, VP of Research, Security and Trust, IDC. “Boards, insurers and regulators are pushing security teams from conversations about the number of vulnerabilities to how much risk remains. Organizations that embrace exposure management principles can reduce risk, improve remediation efficiency, and demonstrate measurable progress to stakeholders.”

More information about the Tenable One Exposure Management Platform is available at: https://www.tenable.com/products/tenable-one

About Tenable
Tenable® is the exposure management company, exposing and closing the cybersecurity gaps that erode business value, reputation and trust. The company’s AI-powered exposure management platform radically unifies security visibility, insight and action across the attack surface, equipping modern organizations to protect against attacks from IT infrastructure to cloud environments to critical infrastructure and everywhere in between. By protecting enterprises from security exposure, Tenable reduces business risk for over 40,000 customers around the globe. Learn more at tenable.com.

Media Contact:
Tenable
tenablepr@tenable.com

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) — At the end of the settlement date of August 31, 2026, short interest in 3,860 Nasdaq Global MarketSM securities totaled 18,212,067,019 shares compared with 17,667,604,951 shares in 3,855 Global Market issues reported for the prior settlement date of August 14, 2026. The August short interest represents 3.52 days compared with 2.98 days for the prior reporting period.

Short interest in 1,655 securities on The Nasdaq Capital MarketSM totaled 4,373,853,400 shares at the end of the settlement date of August 14, 2026, compared with 4,380,876,320 shares in 1,656 securities for the previous reporting period. This represents a 1.61 day average daily volume; the previous reporting period’s figure was 1.22.

In summary, short interest in all 5,515 Nasdaq® securities totaled 22,585,920,419 shares at the August 31, 2026 settlement date, compared with 5,511 issues and 22,048,481,271 shares at the end of the previous reporting period. This is 2.86 days average daily volume, compared with an average of 2.31 days for the prior reporting period.

The open short interest positions reported for each Nasdaq security reflect the total number of shares sold short by all broker/dealers regardless of their exchange affiliations. A short sale is generally understood to mean the sale of a security that the seller does not own or any sale that is consummated by the delivery of a security borrowed by or for the account of the seller.

For more information on Nasdaq Short interest positions, including publication dates, visit
https://www.nasdaq.com/market-activity/quotes/short-interest
or http://www.nasdaqtrader.com/asp/short_interest.asp.

Nasdaq Short Interest Days

About Nasdaq:
Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.     

Media Contact: 
Sam Raffalli
sam.raffalli@nasdaq.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3ca80e4f-bef1-48be-af7c-d12c823675b1

NDAQO

Adams Fairacre Farms, King Arthur Baking Company, and the City of Pittsfield, MA honored for excellence in sustainability

RUTLAND, Vt., Sept. 10, 2026 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (Nasdaq: CWST) (“Casella”), a regional solid waste, recycling, and resource management services company, has honored three organizations for their leadership in sustainability as part of Casella’s annual Sustainability Leadership Awards.

The Casella Sustainability Leadership Awards recognize customers who demonstrate what can be achieved through collaboration to reduce waste, increase recycling, and advance the circular economy. Each year, winners are selected from a diverse group of nominees, including municipalities, businesses, manufacturers, and higher education and healthcare institutions.

“Congratulations to Adams Fairacre Farms, King Arthur Baking Company, and the City of Pittsfield on this well-deserved recognition,” said Ned Coletta, President and CEO of Casella. “The most effective sustainability solutions are the ones that deliver real environmental and economic value. These organizations are showing what can be accomplished when strong partnerships are combined with a willingness to rethink how resources are managed. We’re proud to work alongside them and recognize the meaningful progress they are making in their organizations and communities.”

From implementing innovative waste diversion programs to transforming municipal recycling systems, this year’s award recipients demonstrate the environmental and economic benefits of thoughtful materials management.

Their stories are featured at casella.com/sla, where visitors can learn more about how they are reducing waste and helping create more sustainable communities.

2026 Casella Sustainability Leadership Award Winners

Adams Fairacre Farms is a family-owned grocery and garden center business that began as a small farmstand and has grown into a beloved regional retailer in the Hudson Valley of New York. Adams Fairacre has worked in partnership with the local Casella team to add compost service at all five of its locations. With a focus on keeping the service clear and simple, the teams have established a successful program that reliably recovers clean food waste for local composters. The initiative benefits the organization while also supporting sustainability in the local community.

King Arthur Baking Company is a more than 200-year-old, employee-owned Certified B Corporation, and a nationally recognized baking brand headquartered in Vermont’s Upper Valley Region. As part of its 2023 sustainability strategy, the organization has set a zero-waste goal and a commitment to work towards packaging with 50% post-consumer recycled content. To support these goals, Casella provides monthly diversion reports, educational resources, and ongoing service enhancements. King Arthur was an early adopter of the first Casella ARC™ Operation, through which local manufacturers collaborated to establish a specialty recycling facility tailored to their unique needs.

The City of Pittsfield, MA, Berkshire County’s largest city and home to approximately 43,000 residents, recently worked with Casella to complete a major overhaul of its solid waste service model, transitioning from unlimited curbside pickup to a standardized cart system designed to drive higher recycling rates while reducing waste costs. Elements of the program include automated collection for safety and efficiency, 48-gallon carts to encourage recycling, and a mobile app to provide residential service notifications and recycling education. Following these changes, recycling volumes have risen by 20%, helping reduce the municipality’s reliance on shrinking regional disposal capacity.

About Casella Waste Systems, Inc.

Casella Waste Systems, Inc., headquartered in Rutland, Vermont, provides resource management expertise and services to residential, commercial, municipal, institutional and industrial customers, primarily in the areas of solid waste collection and disposal, transfer, recycling and organics services in the eastern United States. For more information, visit www.casella.com.

Contact Us

Media Relations 
Jeff Weld
Vice President of Communications
(802) 772-2234
Investor Relations 
Henry Baby, CFA
Vice President of Investor Relations and Finance
(802) 417-3841

LYNNWOOD, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) — Zumiez Inc. (NASDAQ: ZUMZ) a leading specialty retailer of apparel, footwear, equipment and accessories for young men and women, today reported results for the second quarter ended August 1, 2026.

Net sales for the second quarter ended August 1, 2026 (13 weeks) decreased 2.5% to $209.0 million from $214.3 million in the second quarter ended August 2, 2025 (13 weeks).   Comparable sales for the thirteen weeks ended August 1, 2026, decreased 2.1%. Net loss in the second quarter of fiscal 2026 was $2.7 million, or $0.17 per share, compared to a net loss of $1.0 million, or $0.06 per share, in the second quarter of the prior fiscal year.

Total net sales for the six months (26 weeks) ending August 1, 2026 increased 0.9% to $402.3 million from $398.6 million reported for the six months (26 weeks) ending August 2, 2025.   Comparable sales increased 0.7% for the twenty-six weeks ended August 1, 2026. Net loss for the first six months of fiscal 2026 was $16.0 million, or $1.00 per share, compared to a net loss for the first six months of fiscal 2025 of $15.3 million, or $0.88 per share.

On August 1, 2026, the Company had cash and current marketable securities of $97.3 million compared to cash and current marketable securities of $106.7 million on August 2, 2025. The decrease was primarily driven by $34.5 million related to share repurchases and $10.6 million of capital expenditures partially offset by $35.7 million of cash flow from operations. The Company repurchased 1.2 million shares during the second quarter of 2026 at an average cost including commission of $19.30 per share and a total cost of $23.2 million. Fiscal year-to-date through August 1, 2026, the Company has repurchased 1.5 million shares at an average cost including commission of $20.07 per share and a total cost of $29.5 million.

“Second quarter results came in below last year driven by weaker performance in the U.S., which was primarily driven by continued softness in footwear as well as lower traffic levels,” said Rick Brooks, Chief Executive Officer of Zumiez Inc. “The decline in the U.S. business was partially offset by continued growth across our other regions, underscoring the strength and diversification of our global business. Our back-to-school trend was similar to our second quarter results with the U.S. being our toughest performing market after two years of low double digit comparable store sales growth for the same periods, partially offset by comparable sales gains internationally. As we look forward to the holiday season, we remain focused on refining our merchandise assortments and deepening our customer experience initiatives to improve the trajectory.”

Third Quarter To-Date

Third quarter-to-date net sales for the 37 days ending September 7, 2026, decreased 4.3%, compared with the 37-day period in the prior year ending September 8, 2025. Comparable sales over the same period are down 3.5%.

Fiscal 2026 Third Quarter Outlook

The Company is introducing guidance for the three months ending October 31, 2026. Net sales are projected to be in the range of $222 to $226 million. Earnings per share are expected to be between $0.00 and $0.10.

In fiscal 2026 the Company currently intends to open approximately 5 new stores all located in North America and close roughly 16 stores, including 10 in North America and 6 internationally.

Conference call Information

To access the conference call, please pre-register using this link (Registration Link). Registrants will receive confirmation with dial-in details. The conference call will also be available to interested parties through a live webcast at https://ir.zumiez.com. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at https://ir.zumiez.com.

About Zumiez Inc.

Zumiez is a leading specialty retailer of apparel, footwear, accessories and hardgoods for young men and women who want to express their individuality through the fashion, music, art and culture of action sports, streetwear, and other unique lifestyles. As of August 29, 2026, we operated 714 stores, including 561 in the United States, 45 in Canada, 81 in Europe and 27 in Australia. We operate under the names Zumiez, Blue Tomato and Fast Times. Additionally, we operate ecommerce web sites at zumiez.com, zumiez.ca, blue-tomato.com and fasttimes.com.au.

Safe Harbor Statement

Certain statements in this press release and oral statements relating thereto made from time to time by representatives of the Company may constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. These statements include, without limitation, predictions and guidance relating to the Company’s future financial performance, brand and product category diversity, ability to adjust product mix, integration of acquired businesses, growing customer demand for our products and new store openings. In some cases, you can identify forward-looking statements by terminology such as, “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. These forward-looking statements are based on management’s current expectations, but they involve a number of risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of risks and uncertainties, which include, without limitation, those described in the Company’s annual report on Form 10-K for the fiscal year ended February 1, 2025 as filed with the Securities and Exchange Commission and available at www.sec.gov. You are urged to consider these factors carefully in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

 
ZUMIEZ INC.
CONDENSED CONSOLIDATED STATEMENTS OF LOSS
(In thousands, except per share amounts)
(Unaudited)
     
    Three Months Ended
    August 1, 2026   % of Sales   August 2, 2025   % of Sales
Net sales   $ 208,964     100.0 %   $ 214,275     100.0 %
Cost of goods sold     135,113     64.7 %     138,257     64.5 %
Gross profit     73,851     35.3 %     76,018     35.5 %
Selling, general and administrative expenses     75,175     35.9 %     75,911     35.4 %
Operating loss (profit)     (1,324 )   -0.6 %     107     0.1 %
Interest income, net     645     0.3 %     753     0.3 %
Other expense (income), net     (753 )   -0.4 %     52     0.0 %
Loss (profit), before income taxes     (1,432 )   -0.7 %     912     0.4 %
Provision for income taxes     1,311     0.6 %     1,914     0.9 %
Net loss   $ (2,743 )   -1.3 %   $ (1,002 )   -0.5 %
Basic loss per share   $ (0.17 )       $ (0.06 )    
Diluted loss per share   $ (0.17 )       $ (0.06 )    
                     
Weighted average shares used in computation of earnings per share                
Basic     15,708           16,698      
Diluted     15,708           16,698      
                     
    Six Months Ended
    August 1, 2026   % of Sales   August 2, 2025   % of Sales
Net sales   $ 402,313     100.0 %   $ 398,618     100.0 %
Cost of goods sold     267,119     66.4 %     267,285     67.1 %
Gross profit     135,194     33.6 %     131,333     32.9 %
Selling, general and administrative expenses     151,710     37.7 %     151,098     37.9 %
Operating loss     (16,516 )   -4.1 %     (19,765 )   -5.0 %
Interest income, net     1,494     0.4 %     3,008     0.8 %
Other expense (income), net     (865 )   -0.2 %     1,895     0.5 %
Loss, before income taxes     (15,887 )   -3.9 %     (14,862 )   -3.7 %
Provision for income taxes     122     0.1 %     471     0.1 %
Net loss   $ (16,009 )   -4.0 %   $ (15,333 )   -3.8 %
Basic loss per share   $ (1.00 )       $ (0.88 )    
Diluted loss per share   $ (1.00 )       $ (0.88 )    
                     
Weighted average shares used in computation of loss per share:                    
Basic     15,955           17,403      
Diluted     15,955           17,403      
                     

 
ZUMIEZ INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
             
    August 1, 2026   January 31, 2026   August 2, 2025
    (Unaudited)       (Unaudited)
Assets            
Current assets            
Cash and cash equivalents   $ 50,288     $ 127,860     $ 78,804  
Marketable securities     46,977       32,764       27,936  
Receivables     25,233       13,957       22,042  
Inventories     157,282       146,995       157,722  
Prepaid expenses and other current assets     16,507       14,407       14,258  
Total current assets     296,287       335,983       300,762  
Fixed assets, net     68,290       72,813       77,756  
Operating lease right-of-use assets     214,226       185,604       193,809  
Goodwill     15,531       15,519       15,334  
Intangible assets, net     15,103       15,513       14,853  
Deferred tax assets, net     6,310       6,349       8,781  
Other long-term assets     11,643       12,390       12,093  
Total long-term assets     331,103       308,188       322,626  
Total assets   $ 627,390     $ 644,171     $ 623,388  
             
Liabilities and Shareholders’ Equity            
Current liabilities            
Trade accounts payable   $ 68,141     $ 49,150     $ 69,181  
Accrued payroll and payroll taxes     20,281       28,221       21,443  
Operating lease liabilities     59,203       54,023       55,608  
Other current liabilities     25,180       36,136       24,777  
Total current liabilities     172,805       167,530       171,009  
Long-term operating lease liabilities     168,001       145,306       153,115  
Other long-term liabilities     7,571       7,050       6,827  
Total long-term liabilities     175,572       152,356       159,942  
Total liabilities     348,377       319,886       330,951  
             
Shareholders’ equity            
Preferred stock, no par value, 20,000 shares authorized; none issued and outstanding     —       —       —  
Common stock, no par value, 50,000 shares authorized; 15,854 shares issued and outstanding at August 1, 2026, 16,971 shares issued and outstanding at January 31, 2026, and 17,221 shares issued and outstanding at August 2, 2025     215,742       211,764       207,388  
Accumulated other comprehensive loss     (14,994 )     (11,438 )     (15,684 )
Retained earnings     78,265       123,959       100,733  
Total shareholders’ equity     279,013       324,285       292,437  
Total liabilities and shareholders’ equity   $ 627,390     $ 644,171     $ 623,388  
                         

 
ZUMIEZ INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
     
    Six Months Ended
    August 1, 2026   August 2, 2025
Cash flows from operating activities:        
Net loss   $ (16,009 )   $ (15,333 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation, amortization and accretion     9,640       10,707  
Noncash lease expense     32,589       31,452  
Deferred taxes     44       (81 )
Stock-based compensation expense     3,944       3,621  
Impairment of long-lived assets     598       777  
Other     703       (693 )
Changes in operating assets and liabilities:        
Receivables     (7,815 )     (6,768 )
Inventories     (11,769 )     (7,540 )
Prepaid expenses and other assets     (1,778 )     (1,836 )
Trade accounts payable     19,787       18,682  
Accrued payroll and payroll taxes     (7,772 )     (1,070 )
Income taxes payable     (11,145 )     (4,775 )
Operating lease liabilities     (34,650 )     (35,065 )
Other liabilities     (3,643 )     (1,579 )
Net cash used in operating activities     (27,276 )     (9,501 )
         
Cash flows from investing activities:        
Additions to fixed assets     (4,880 )     (5,317 )
Purchases of marketable securities     (28,512 )     (8,044 )
Sales and maturities of marketable securities     13,510       16,881  
Net cash (used in) provided by investing activities     (19,882 )     3,520  
         
Cash flows from financing activities:        
Proceeds from revolving credit facilities     16,441       –  
Payments on revolving credit facilities     (16,441 )     –  
Proceeds from the issuance and exercise of stock-based awards, net of tax     34       185  
Repurchase of common stock     (28,972 )     (32,682 )
Net cash used in financing activities     (28,938 )     (32,497 )
         
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     (1,605 )     1,614  
Net decrease in cash, cash equivalents, and restricted cash     (77,701 )     (36,864 )
Cash, cash equivalents, and restricted cash, beginning of period     134,113       121,529  
Cash, cash equivalents, and restricted cash, end of period   $ 56,412     $ 84,665  
Supplemental disclosure on cash flow information:        
Cash paid during the period for income taxes   $ 11,146     $ 5,452  
Accrual for purchases of fixed assets     1,409       1,180  
Accrual for repurchase of common stock     714       426  
         

Company Contact:
Darin White
Director of Finance &
Investor Relations
Zumiez Inc.
(425) 551-1500, ext. 1337

Investor Contact:
ICR
Brendon Frey
(203) 682-8200

Net Cash Proceeds of $79 Million After Repayment of Secured Loans
Remainder of Sale Portfolio Expected to Close in the Fourth Quarter 

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHP) (the “Company”) announced today that it has completed the primarily multi-tenant first tranche of its previously announced sale of 86 outpatient medical facilities (“OMFs”) for approximately $528 million. The closing of the remaining 56 OMFs, which are subject to the buyer’s assumption of approximately $220 million of secured debt (Secured Term Loan 4 due 2033) and customary closing conditions, is expected to occur in the fourth quarter of 2026.

In connection with the sale, the Company repaid in full its Secured Term Loan 1 due 2028 and Secured Term Loan 3 due in 2031, totaling $119 million. This amount includes the repayment of $60 million of debt encumbering other OMFs not among the 86 properties to be sold, further reducing the Company’s secured indebtedness and increasing its overall capital flexibility. The sale generated approximately $79 million in net cash proceeds, before transaction expenses, property operating prorations and other adjustments.

About National Healthcare Properties

National Healthcare Properties, Inc. (Nasdaq: NHP) is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States. Additional information about the Company can be found on its website at nhpreit.com.

Investor & Media Contact

Email: ir@nhpreit.com

Cautionary Statement Regarding Forward-Looking Statements

This press release may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of terminology such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “should,” “predict,” “project,” “potential,” “continue” or the negatives of these terms or variations of them or similar expressions. Examples of forward-looking statements include statements regarding the closing of OMF disposition, the timing and expected benefits of the OMF disposition, future disposition opportunities and other statements regarding the Company’s future strategy. Risks and uncertainties, the occurrence of which could adversely affect the Company’s business and cause actual results to differ materially from those expressed or implied in the forward-looking statements, include, but are not limited to, the following: changes in economic cycles generally and in the real estate and healthcare markets specifically; the success of the Company’s growth strategy, including its ability to successfully identify, complete and integrate new acquisitions; the Company’s ability to complete acquisitions or dispositions on the terms and timing the Company expects, or at all; changes to inflation and interest rates; competition in the real estate and healthcare markets; the Company’s ability to retain certain key personnel; legislative and regulatory changes in the healthcare and real estate industries; reductions or changes in reimbursement from third-party payors, including Medicare and Medicaid; discovery of previously undetected environmentally hazardous conditions; the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; system failures, cyber incidents or deficiencies in the Company’s cybersecurity systems; the availability of capital on favorable terms, or at all; the Company’s ability to remain qualified as a real estate investment trust for U.S. federal income tax purposes; and other risks and uncertainties described in the section titled Risk Factors of the Company’s most recent Annual Report on Form 10-K and all other filings with the Securities and Exchange Commission. Finally, the Company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

GAITHERSBURG, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer; Dr. Michelle Williams, Chief Scientific Officer; and Matthew Ferguson, Chief Financial Officer, will present and host one-on-one meetings with investors at the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel in New York City on September 15–16, 2026.

During the presentation, management will discuss how Elutia is working to address post-surgical infection in plastic and reconstructive surgeries—one of the most significant challenges facing patients and surgeons—through its drug-eluting biomatrix technology designed to support safer, more reliable reconstructive outcomes.

The presentation will begin at 4:30 pm Eastern Time on Tuesday, September 15, 2026, and can be accessed live here. This presentation will take the place of our previously announced pre-recorded presentation. Elutia will also host one-on-one meetings with investors on September 15–16, 2026. To schedule a one-on-one meeting, conference attendees should visit H.C. Wainwright.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Elutia Investor Relations
ir@elutia.com

HUNTSVILLE, AL, Sept. 10, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology enabling drug product candidates to treat neurological diseases and other indications, today announced that Steve Ledger, Chief Executive Officer, will present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. The Company will also attend one-on-one investor meetings during the conference taking place September 14-16, 2026 in New York, New York.

The presentation will be available for on-demand viewing starting on Monday, September 14, 2026, at 7:00 a.m. ET at this link.

About Serina Therapeutics

Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s proprietary POZ Platform™ drug optimization technology is designed to improve the integrated efficacy and safety profile of multiple therapeutic modalities, including small molecules, RNA-based therapeutics and antibody-drug conjugates. The Company’s lead program, SER-252 (POZ-apomorphine), is being developed as a long-acting treatment for advanced Parkinson’s disease. For more information, please visit https://serinatx.com.

For inquiries, please contact:
Stefan Riley
sriley@serinatherapeutics.com
(256) 327-9630

  • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth
  • Nine new logo wins in the fourth quarter, including two strategic AI Agent wins
  • Strong operating cash flow of $24.8 million and free cash flow of $21.7 million in the fourth quarter
  • Record full-year revenue, net income, adjusted net income, adjusted EBITDA, EPS, adjusted EPS, operating cash flow, and free cash flow
  • Full-year revenue grew over 15% versus prior year; full-year diluted EPS grew 33% to $3.13, full-year adjusted EPS grew 28% to $3.52
  • Introduces fiscal year and first quarter 2027 guidance, forecasting continued strong revenue and adjusted EBITDA growth

WASHINGTON, Sept. 10, 2026 (GLOBE NEWSWIRE) — IBEX Limited (“ibex”) (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced financial results for its fourth quarter and fiscal year ended June 30, 2026.

  Three months ended June 30,   Twelve months ended June 30,
($ millions, except per share amounts) 2026   2025   Change   2026   2025   Change
Revenue(2) $ 164.3     $ 147.1     11.6 %   $ 644.1     $ 558.3     15.4 %
Net income(2) $ 8.7     $ 9.6     (8.8 )%   $ 46.3     $ 36.9     25.7 %
Net income margin(2)   5.3 %     6.5 %   (120) bps     7.2 %     6.6 %   60 bps
Adjusted net income(1) $ 12.7     $ 12.6     0.8 %   $ 52.2     $ 43.0     21.3 %
Adjusted net income margin(1)   7.7 %     8.5 %   (80) bps     8.1 %     7.7 %   40 bps
Adjusted EBITDA(1, 2) $ 20.2     $ 20.5     (1.3 )%   $ 82.4     $ 72.0     14.5 %
Adjusted EBITDA margin(1)   12.3 %     13.9 %   (160) bps     12.8 %     12.9 %   (10) bps
Earnings per share – diluted(1,2) $ 0.59     $ 0.66     (11.3   )%   $ 3.13     $ 2.36     32.8 %
Adjusted earnings per share – diluted(1,2) $ 0.85     $ 0.87     (1.9 )%   $ 3.52     $ 2.75     28.3 %
                       
(1) See accompanying Exhibits for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.
(2) The current period percentages are calculated based on exact amounts, and therefore may not recalculate exactly using rounded numbers as presented.
 

“ibex delivered another record-breaking quarter with revenue growth of 12% to $164.3 million, our sixth straight double-digit growth quarter, capping off an amazing year with top-line organic growth of over 15%, and adjusted EPS growth of over 28%,” said Bob Dechant, ibex CEO. “Our differentiation continues to shine, enabling us to win new trophy clients and outperform our competition operationally which leads to significant market share gains.”

“Fiscal 2026 also marked a transformational step forward as ibex defined a new era of BPO, one powered by AI agents. Our strategic partnership with Sierra, a leader in conversational AI, has firmly strengthened our leadership position in this evolving market. To date, we have delivered more than 10 successful AI Agent implementations across five verticals. Momentum continues to build for these solutions, further separating us from traditional BPO providers.”

Fourth Quarter Financial Performance
Revenue

  • Revenue of $164.3 million, an increase of 11.6% from $147.1 million in the prior year quarter, was driven by strong performance across four verticals: HealthTech (+42.3%), Technology (+27.4%), Travel, Transportation and Logistics (+17.8%), and Retail & E-Commerce (+7.0%), with accelerating growth in our Wave iX solutions.

Net Income and Earnings Per Share

  • Net income of $8.7 million decreased from $9.6 million in the prior year quarter.
  • Diluted earnings per share decreased to $0.59 compared to $0.66 in the prior year quarter.
  • Net income margin decreased to 5.3% compared to 6.5% in the prior year primarily driven by training costs related to new client wins and the temporary impact of work transferring from nearshore to offshore delivery centers.
  • Non-GAAP adjusted net income remained relatively consistent at $12.7 million when compared to the prior year quarter (see Exhibit 1 for reconciliation).
  • Non-GAAP adjusted diluted earnings per share was $0.85 compared to $0.87 in the prior year quarter (see Exhibit 1 for reconciliation). 

Adjusted EBITDA

  • Adjusted EBITDA was $20.2 million compared to $20.5 million in the prior year quarter (see Exhibit 2 for reconciliation).
  • Adjusted EBITDA margin decreased to 12.3% compared to 13.9% in the prior year quarter (see Exhibit 2 for reconciliation).

Fiscal Year 2026 Financial Performance
Revenue

  • Revenue of $644.1 million, an increase of 15.4% from $558.3 million in the prior year, was driven by broad-based growth across four verticals: HealthTech (+38.5%), Technology (+25.6%) Travel, Transportation and Logistics (+17.2%), and Retail & E-commerce (+14.1%), with growth in our Wave iX solutions and digital acquisition business.

Net Income and Earnings Per Share

  • Net income increased to $46.3 million compared to $36.9 million in the prior year. Net income was favorably impacted by revenue growth in our higher margin offshore regions as well as lower selling, general, and administrative and income tax expenses as a percentage of revenue compared to the prior year.
  • Diluted earnings per share increased to $3.13 compared to $2.36 in the prior year.
  • Net income margin increased to 7.2% compared to 6.6% in the prior year.
  • Non-GAAP adjusted net income increased to $52.2 million compared to $43.0 million in the prior year (see Exhibit 1 for reconciliation).
  • Non-GAAP adjusted diluted earnings per share increased to $3.52 compared to $2.75 in the prior year (see Exhibit 1 for reconciliation).

Adjusted EBITDA

  • Adjusted EBITDA increased to $82.4 million compared to $72.0 million in the prior year (see Exhibit 2 for reconciliation).
  • Adjusted EBITDA margin remained relatively consistent at 12.8% when compared to the prior year (see Exhibit 2 for reconciliation). 

Cash Flow and Balance Sheet

  • Capital expenditures were $27.8 million compared to $18.4 million in the prior year. The planned increase in capital expenditures during the year was driven by expansions in our offshore regions and purchases of IT and telecommunications equipment to support the Company’s continued growth.
  • Cash flow from annual operating activities increased to a record of $59.0 million compared to $45.7 million in the prior year. The increase was primarily driven by an increase in revenue and profit, offset by a higher use of working capital.
  • Free cash flow of $21.7 million for the fourth quarter contributed to record annual free cash flow of $31.2 million, up from $27.3 million in the prior year (see Exhibit 3 for reconciliation).
  • Net cash was $30.9 million, an improvement of $17.2 million compared to net cash of $13.7 million as of June 30, 2025 (see Exhibit 4 for reconciliation).
  • Repurchased 0.1 million shares in the fourth quarter for $4.3 million at an average price of $29.83. Repurchased approximately 0.5 million shares for $14.4 million at an average price of $31.70 during fiscal year 2026.

Fiscal Year and First Quarter Fiscal 2027 Business Outlook
“Fiscal 2026 was a banner year that included record performance across many key operating metrics, including revenue, adjusted EBITDA, EPS, and free cash flow. Our financial results were driven by consistent performance throughout the year, supported by our differentiated strategy and increased traction in our AI-enabled solution offerings. Looking ahead, this momentum gives us confidence that our strategy will continue generating results that outpace our market as we head to fiscal year 2027,” said Taylor Greenwald, CFO of ibex.

“Forecasting the year ahead, our healthy balance sheet and cash flows are enabling us to continue to make smart investments to support increased capacity for anticipated growth as well as to further extend our current AI leadership position. Reflective of our current position and forward momentum, we are providing initial first quarter and fiscal year 2027 revenue and adjusted EBITDA guidance.”

Fiscal Year and First Quarter Fiscal 2027 Guidance

  • For fiscal year 2027, revenue is expected to be in the range of $700 to $715 million for 9-11% growth. Adjusted EBITDA is expected to be in the range of $90 to $94 million for 9-14% growth.
  • For first quarter fiscal year 2027, revenue is expected to be in the range of $168 to $170 million for 11-12% growth. Adjusted EBITDA is expected to be in the range of $22 to $23 million for 13-18% growth.
  • Capital expenditures for the year are expected to be in the range of $25 to $30 million.

Conference Call and Webcast Information
IBEX Limited will host a conference call and live webcast to discuss its fourth quarter and fiscal year 2026 financial results at 4:30 p.m. Eastern Time today, September 10, 2026. We will also post to this section of our website the earning slides, which will accompany our conference call and live webcast, and encourage you to review the information that we make available on our website.

Live and archived webcasts can be accessed at: https://investors.ibex.co/.

Non-GAAP Financial Measures
We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures provide a more helpful depiction of our performance of the business by encompassing only relevant and manageable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our operating results as reported in accordance with accounting principles generally accepted in the United States (“GAAP”). Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under GAAP and should not be considered as alternatives to operating profit or net income / (loss) or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with GAAP.

ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA to the most directly comparable GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, foreign currency gains and losses, and stock-based compensation expense. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period.

About ibex
ibex is a global leader in outsourced business services and AI-powered customer experience solutions, enabling the world’s best brands to deliver truly differentiated experiences for their customers. Leveraging a global team of approximately 35,000 human CX experts – powered by the best AI technology, decades of CX innovation, and deep business insights – ibex engineers seamless, end-to-end customer journeys from AI agents to human agents at scale across retail, e-commerce, healthcare, fintech, utilities, technology, logistics, and more. Discover more at ibex.co and connect with us on LinkedIn.

Forward Looking Statements
In addition to historical information, this press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” “forecast,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: our ability to attract new business and retain key clients; our profitability based on our utilization, pricing and managing costs; our access to financing to support our operations and growth; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities and current trends toward outsourcing services may reverse; our ability to compete effectively in our industry; general economic uncertainty in global markets and unfavorable economic conditions, including inflation, rising interest rates, recession, and foreign exchange fluctuations; our ability to manage our international operations, particularly in the Philippines, Jamaica, Pakistan and Nicaragua; natural events, health epidemics, global geopolitical conditions, including developing or ongoing conflicts, widespread civil unrest, terrorist attacks and other attacks of violence involving any of the countries in which we or our clients operate; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands, including the effective adoption of Artificial Intelligence into our offerings; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security, employment and anti-corruption; the effect of cyberattacks or cybersecurity vulnerabilities on our information technology systems; the impact of tax matters, including new legislation and actions by taxing authorities; and other factors discussed in the “Risk Factors” described in our periodic reports filed with the U.S. Securities and Exchange Commission (“SEC”), including our annual reports on Form 10-K, quarterly reports on Form 10-Q, and past filings on Form 20-F, and any other risk factors we include in subsequent filings with the SEC. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

IR Contact:  ir@ibex.co
Media Contact:  Daniel Burris, VP, Marketing and Communication, ibex, daniel.burris@ibex.co

 
IBEX LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(Unaudited)
(in thousands)
 
  June 30,
2026
  June 30,
2025
Assets      
Current assets      
Cash and cash equivalents $ 32,566     $ 15,350  
Accounts receivable, net   125,292       117,136  
Prepaid expenses   15,205       9,443  
Due from related parties   —       40  
Tax advances and receivables   4,226       1,522  
Other current assets   2,348       2,128  
Total current assets   179,637       145,619  
       
Non-current assets      
Property and equipment, net   40,725       32,563  
Operating lease assets   55,496       62,276  
Goodwill   11,832       11,832  
Deferred tax asset, net   7,170       7,163  
Other non-current assets   14,275       13,762  
Total non-current assets   129,498       127,596  
Total assets $ 309,135     $ 273,215  
       
Liabilities and stockholders’ equity      
Current liabilities      
Accounts payable and accrued liabilities $ 22,996     $ 18,692  
Accrued payroll and employee-related liabilities   40,914       38,588  
Current deferred revenue   6,384       5,498  
Current operating lease liabilities   13,936       14,332  
Current debt   882       823  
Due to related parties   —       22  
Income taxes payable   427       1,986  
Total current liabilities   85,539       79,941  
       
Non-current liabilities      
Non-current deferred revenue   2,075       1,130  
Non-current operating lease liabilities   46,849       53,804  
Long-term debt   777       796  
Other non-current liabilities   3,665       3,235  
Total non-current liabilities   53,366       58,965  
Total liabilities   138,905       138,906  
       
Stockholders’ equity      
Common shares   2       1  
Treasury shares   (117,703 )     (103,338 )
Additional paid-in capital   227,346       218,241  
Accumulated other comprehensive loss   (11,487 )     (6,336 )
Retained earnings   72,072       25,741  
Total stockholders’ equity   170,230       134,309  
Total liabilities and stockholders’ equity $ 309,135     $ 273,215  

 
IBEX LIMITED AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
(Unaudited)
(in thousands, except per share data)
 
  Three months ended June 30,   Twelve months ended June 30,
    2026       2025       2026       2025  
Revenue $ 164,269     $ 147,138     $ 644,076     $ 558,273  
               
Cost of services (exclusive of depreciation and amortization presented separately below)   117,349       100,872       456,169       385,692  
Selling, general and administrative   31,474       29,756       113,021       108,738  
Depreciation and amortization   5,624       4,248       19,922       17,232  
Total operating expenses   154,447       134,876       589,112       511,662  
Income from operations   9,822       12,262       54,964       46,611  
               
Interest income   115       29       266       955  
Interest expense   (222 )     (448 )     (936 )     (1,634 )
Income before income taxes   9,715       11,843       54,294       45,932  
               
Provision for income tax expense   (968 )     (2,247 )     (7,963 )     (9,068 )
Net income $ 8,747     $ 9,596     $ 46,331     $ 36,864  
               
Other comprehensive income / (loss)              
Foreign currency translation adjustments $ (436 )   $ 263     $ (3,140 )   $ 1,114  
Unrealized gain / (loss) on cash flow hedging instruments, net of tax   1,748       204       (2,535 )     775  
Actuarial gain / (loss) on defined benefit plan   524       (312 )     524       (312 )
Total other comprehensive income / (loss)   1,836       155       (5,151 )     1,577  
Total comprehensive income $ 10,583     $ 9,751     $ 41,180     $ 38,441  
               
Net income per share              
Basic $ 0.65     $ 0.72     $ 3.45     $ 2.51  
Diluted $ 0.59     $ 0.66     $ 3.13     $ 2.36  
               
Weighted average common shares outstanding              
Basic   13,372       13,380       13,414       14,678  
Diluted   14,892       14,491       14,808       15,725  

 
IBEX LIMITED AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
(in thousands)
 
  Three months ended June 30,   Twelve months ended June 30,
    2026       2025       2026       2025  
CASH FLOWS FROM OPERATING ACTIVITIES              
Net income $ 8,747     $ 9,596     $ 46,331     $ 36,864  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization   5,624       4,248       19,922       17,232  
Noncash lease expense   3,592       3,358       13,911       13,378  
Noncash gain on lease terminations   (85 )     —       (85 )     —  
Deferred income tax   782       (1,168 )     (8 )     (2,877 )
Stock-based compensation expense   3,285       1,926       7,737       5,432  
Allowance of expected credit losses   114       86       427       514  
Impairment losses   1,092       1,429       1,092       1,429  
Change in assets and liabilities:              
Decrease / (increase) in accounts receivable   3,695       2,788       (8,659 )     (19,262 )
(Increase) / decrease in prepaid expenses and other current assets   (983 )     (31 )     (11,356 )     361  
Increase in accounts payable and accrued liabilities   3,051       9,290       2,506       6,248  
(Decrease) / increase in deferred revenue   (204 )     (451 )     1,830       752  
Decrease in operating lease liabilities   (3,887 )     (3,134 )     (14,647 )     (14,403 )
Net cash inflow from operating activities   24,823       27,937       59,001       45,668  
               
CASH FLOWS FROM INVESTING ACTIVITIES              
Purchase of property and equipment   (3,163 )     (5,159 )     (27,807 )     (18,375 )
Net cash outflow from investing activities   (3,163 )     (5,159 )     (27,807 )     (18,375 )
               
CASH FLOWS FROM FINANCING ACTIVITIES              
Proceeds from line of credit   3,000       13,400       38,600       82,710  
Repayments of line of credit   (3,000 )     (32,500 )     (38,600 )     (82,710 )
Proceeds from the exercise of options   195       773       4,009       4,307  
Taxes paid related to net share settlement of equity awards   (36 )     —       (2,338 )     —  
Principal payments on finance leases   (383 )     (314 )     (1,216 )     (953 )
Purchase of treasury shares   (4,249 )     (1,593 )     (14,382 )     (78,014 )
Net cash outflow from financing activities   (4,473 )     (20,234 )     (13,927 )     (74,660 )
Effects of exchange rate difference on cash and cash equivalents   (30 )     (171 )     (51 )     (3 )
Net increase / (decrease) in cash and cash equivalents   17,157       2,373       17,216       (47,370 )
Cash and cash equivalents, beginning   15,409       12,977       15,350       62,720  
Cash and cash equivalents, ending $ 32,566     $ 15,350     $ 32,566     $ 15,350  

IBEX LIMITED AND SUBSIDIARIES
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

EXHIBIT 1: Adjusted net income, adjusted net income margin, and adjusted earnings per share

We define adjusted net income as net income before the effect of the following items: severance costs, impairment losses, gains or losses on asset disposals, gains or losses on lease terminations, foreign currency gains and losses, and stock-based compensation expense, net of the tax impact of such adjustments. We define adjusted net income margin as adjusted net income divided by revenue. We define adjusted earnings per share as adjusted net income divided by weighted average diluted shares outstanding.

The following table provides a reconciliation of net income to adjusted net income, net income margin to adjusted net income margin, and diluted earnings per share to adjusted earnings per share for the periods presented:

  Three months ended June 30,   Twelve months ended June 30,
($000s, except per share amounts) 2026   2025   2026   2025
Net income $ 8,747     $ 9,596     $ 46,331     $ 36,864  
Net income margin   5.3 %     6.5 %     7.2 %     6.6 %
               
Severance costs   267       558       1,240       558  
Impairment losses   1,092       1,429       1,092       1,429  
Gain on asset disposals   (150 )     —       (150 )     —  
Loss on lease terminations   744       —       744       —  
Foreign currency (gains) / losses   (499 )     27       (3,177 )     693  
Stock-based compensation expense   3,285       1,926       7,737       5,432  
Total adjustments $ 4,739     $ 3,940     $ 7,486     $ 8,112  
Tax impact of adjustments1   (821 )     (969 )     (1,650 )     (1,975 )
Adjusted net income $ 12,665     $ 12,567     $ 52,167     $ 43,001  
Adjusted net income margin   7.7 %     8.5 %     8.1 %     7.7 %
               
Diluted earnings per share $ 0.59     $ 0.66     $ 3.13     $ 2.36  
Per share impact of adjustments to net income   0.26       0.21       0.39       0.39  
Adjusted earnings per share $ 0.85     $ 0.87     $ 3.52     $ 2.75  
 
Weighted average diluted shares outstanding   14,892       14,491       14,808       15,725  

________________________________
1 The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdictions.

EXHIBIT 2:  EBITDA, adjusted EBITDA, and adjusted EBITDA margin

EBITDA is a non-GAAP profitability measure that represents net income before the effect of the following items: interest expense, income tax expense, and depreciation and amortization. Adjusted EBITDA is a non-GAAP profitability measure that represents EBITDA before the effect of the following items: interest income, severance costs, impairment losses, gains or losses on asset disposals, gains or losses on lease terminations, foreign currency gains and losses, and stock-based compensation expense. Adjusted EBITDA margin is a non-GAAP profitability measure that represents adjusted EBITDA divided by revenue.

The following table provides a reconciliation of net income to EBITDA and adjusted EBITDA and net income margin to adjusted EBITDA margin for the periods presented:

  Three months ended June 30,   Twelve months ended June 30,
($000s) 2026   2025   2026   2025
Net income $ 8,747     $ 9,596     $ 46,331     $ 36,864  
Net income margin   5.3 %     6.5 %     7.2 %     6.6 %
               
Interest expense   222       448       936       1,634  
Income tax expense   968       2,247       7,963       9,068  
Depreciation and amortization   5,624       4,248       19,922       17,232  
EBITDA $ 15,561     $ 16,539     $ 75,152     $ 64,798  
Interest income   (115 )     (29 )     (266 )     (955 )
Severance costs   267       558       1,240       558  
Impairment losses   1,092       1,429       1,092       1,429  
Gain on asset disposals   (150 )     —       (150 )     —  
Loss on lease terminations   744       —       744       —  
Foreign currency (gains) / losses   (499 )     27       (3,177 )     693  
Stock-based compensation expense   3,285       1,926       7,737       5,432  
Adjusted EBITDA $ 20,185     $ 20,450     $ 82,372     $ 71,955  
               
Adjusted EBITDA margin   12.3 %     13.9 %     12.8 %     12.9 %


EXHIBIT 3: Free cash flow

We define free cash flow as net cash provided by operating activities less capital expenditures.

  Three months ended June 30,   Twelve months ended June 30,
($000s)   2026       2025       2026       2025  
Net cash provided by operating activities $ 24,823     $ 27,937     $ 59,001     $ 45,668  
Less: capital expenditures   3,163       5,159       27,807       18,375  
Free cash flow $ 21,660     $ 22,778     $ 31,194     $ 27,293  


EXHIBIT 4: Net cash

We define net cash as total cash and cash equivalents less debt.

($000s) June 30, 2026   June 30, 2025
Cash and cash equivalents $ 32,566     $ 15,350  
           
Debt          
Current $ 882     $ 823  
Non-current   777       796  
Total debt $ 1,659     $ 1,619  
Net cash $ 30,907     $ 13,731  

  • Technology transfer to LyFE Manufacturing Center™ completed following FDA review of improved manufacturing process and updated analytical methods
  • Dosing of additional patients with the new process at LyFE continues with the goal of determining the recommended Phase 2 dose and optimized safety management plan to support End-of-Phase 1 discussions with the FDA
  • Additional clinical data from the Phase 1/2 trial of LYL273 in patients with third- or later-line relapsed/refractory metastatic colorectal cancer and End-of-Phase 1 meeting with FDA expected in 2027

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced successful completion of the planned technology transfer for LYL273, a guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate, to its LyFE Manufacturing Center™ (LyFE) in Bothell, Washington, following review by the U.S. Food and Drug Administration (FDA). LyFE is implementing an improved manufacturing process and updated analytical methods to enhance manufacturing performance and increase capacity. The Phase 1/2 clinical trial of LYL273 in patients with relapsed/refractory metastatic colorectal cancer (R/R mCRC) continues to enroll patients with the goal of determining the recommended Phase 2 dose and optimized safety management plan. Additional clinical data from the trial and a planned End-of-Phase 1 meeting with the FDA are now expected in 2027.

“The LYL273 Phase 1/2 clinical trial continues to build momentum. We are activating additional clinical sites for the expansion phase of the trial, with strong interest in the study across our group of highly experienced investigators,” said Lynn Seely, MD, President and Chief Executive Officer of Lyell. “LYL273 has already generated encouraging clinical activity data in patients with metastatic colorectal cancer. We are now focused on determining the recommended Phase 2 dose and optimizing the safety management plan, including with results from patients treated with LYL273 manufactured at LyFE. We look forward to sharing additional clinical data and bringing a more complete data package to the FDA as we plan for our End-of-Phase 1 meeting in 2027.”

About LYL273

LYL273 is a guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate enhanced with CD19 CAR expression and controlled cytokine release, designed to improve CAR T-cell expansion, immune cell infiltration and cancer cell killing in the hostile solid tumor microenvironment. CARABiNER (NCT05319314) is an ongoing Phase 1/2 dose-escalation, dose-expansion trial of LYL273 in the United States in patients with R/R mCRC. Lyell announced in June 2026 safety data from the trial demonstrating that gastrointestinal prophylaxis consisting of infliximab, vedolizumab and budesonide reduced Grade ≥ 2 diarrhea/colitis from 55% without prophylaxis to 10% with prophylaxis. Enrollment in the trial is continuing with dose escalation to determine the recommended Phase 2 dose, including with data from the improved LyFE manufacturing process and analytical methods, as well as to optimize the prophylaxis and safety management plan to calibrate immune suppression.

About Lyell Immunopharma, Inc.

Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. To realize the potential of cell therapy for cancer, Lyell utilizes a suite of technologies to arm CAR T cells with enhancements needed to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical responses, including the ability to resist exhaustion, maintain qualities of durable stemness and function in the hostile tumor microenvironment. Lyell’s proprietary LyFE Manufacturing Center™ has commercial launch capability and is expected to have the capacity to manufacture more than 1,200 CAR T-cell doses per year. To learn more, please visit www.lyell.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding: Lyell’s expectations around the progress of the U.S. Phase 1/2 trial for LYL273, including expectations around patient enrollment and site activation, activities to determine a recommended Phase 2 dose and optimized safety plan and the timing for release of additional clinical data from this trial and a planned End-of-Phase 1 FDA meeting; the potential clinical benefits and therapeutic potential of LYL273; manufacturing activities at LyFE and the capability of LyFE to manufacture drug supply through potential commercial launch and its expected manufacturing capacity; and other statements that are not historical fact. These statements are based on Lyell’s current plans, objectives, estimates, expectations and intentions, are not guarantees of future performance and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, but are not limited to, risks and uncertainties related to: Lyell operates in a rapidly evolving industry and has a limited operating history; Lyell’s ability to successfully develop, manufacture and commercialize product candidates or its experiencing significant delays in doing so; Lyell’s dependence on the enrollment and retention of patients in its current and planned clinical trials for its product candidates; the potential for results of Lyell’s research, nonclinical studies or earlier clinical trials to not be predictive of future results; clinical development involving a lengthy and expensive process with uncertain outcomes; Lyell’s product candidates and technologies being based on novel technologies that are unproven and may not result in approvable or marketable products; Lyell facing substantial competition in a rapidly changing industry, which may result in others discovering, developing or commercializing products before or more successfully than it does; Lyell’s ability to obtain and maintain sufficient intellectual property protection for its product candidates; the complexity of manufacturing cellular therapies; Lyell’s ability to manufacture drug products for its clinical trials itself and any potential delays in further qualifying or in receiving regulatory approvals for any manufacturing facility or product candidates or in expanding its manufacturing capacity; Lyell’s reliance on third parties; implementation of Lyell’s strategic plans for its business and product candidates and Lyell’s realization of the expected benefits of such plans; the potential reduction of Lyell’s cash resources and fluctuations in Lyell’s operating results and financial condition as a result of Lyell’s milestone, royalty and success payment obligations; the sufficiency of Lyell’s capital resources and need for additional capital to achieve its goals; and other risks, including those described under the heading “Risk Factors” in Lyell’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the U.S. Securities and Exchange Commission on August 6, 2026. Forward-looking statements contained in this press release are made as of this date, and Lyell undertakes no duty to update such information except as required under applicable law.

Contact:
Lyell Investor Relations
IR@lyell.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.